title: Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.
authors.affiliation: University of Puerto Rico, School of Medicine, San Juan, Puerto Rico. maldonadosimon@yahoo.com
authors.forename: Norman I
authors.initials: NI
authors.lastname: Maldonado
authors.forename: Fernando
authors.initials: F
authors.lastname: Cabanillas
authors.forename: Elaine S
authors.initials: ES
authors.lastname: Jaffe
authors.forename: Mark
authors.initials: M
authors.lastname: Raffeld
authors.forename: Luis
authors.initials: L
authors.lastname: Lozada
mesh_terms: D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000187:drug effects / Q000821:virology*; D004334:Drug Administration Schedule; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D017403:In Situ Hybridization; D008232:Lymphoproliferative Disorders / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology / Q000821:virology; D008297:Male; D016377:Organ Transplantation / Q000009:adverse effects; D012367:RNA, Viral / Q000302:isolation & purification; D012120:Respiration Disorders / Q000209:etiology; D000069283:Rituximab; D014059:Tongue / Q000473:pathology* / Q000821:virology*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D012367:RNA, Viral; D000069283:Rituximab